FEATURED NEWS

• HDA Statement on “Project Airbridge” Initiative

  March 29, 2020

  Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding today’s White House Coronavirus Task Force briefing and the “Project Airbridge” initiative.

• HDA Statement on FDA Drug Importation Proposal

  March 9, 2020

  In response to the Food and Drug Administration’s (FDA) proposed rule on prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement:

• HDA Statement on COVID-19 Preparedness

  March 5, 2020

  The Healthcare Distribution Alliance (HDA) released the following statement on distribution industry preparedness for the novel COVID-19 “coronavirus” outbreak.

• Conley and Cowman to Lead HDA Research Foundation Board Of Directors

  February 25, 2020

  The HDA Research Foundation announced Michael Conley, Vice President and Head, Trade Operations and Analytics, Novartis Pharmaceuticals Corporation, as Chairman of its Board of Directors. Craig Cowman, Executive Vice President, Global Sourcing, Cardinal Health, is Vice Chairman.

• AAOA Celebrates Two Years of Working with Stakeholders to Help Address Prescription Opioid Safety

  February 25, 2020

  This month, Allied Against Opioid Abuse (AAOA) celebrates its second year of working with stakeholders across the healthcare industry to raise awareness among patients, pharmacists, providers and the public about prescription opioid safety.